Summary table assessment of the use of 26 drug products in the Mini-Sentinel Distributed Database (Warfarin, Ambrisentan, Bosentan, Dronedarone, Lisinopril, Lisinopril/Hydrochlorothiazide, Acitretin, Acitretin/Emollient Comb. 26, Isotretinoin, Methimazole, Methotrexate, Methotrexate Sodium, Clarithromycin, Fluconazole, Telavancin, Busulfan, Chlorambucil, Cyclophosphamide, Lenalidomide, Thalidomide, Trastuzumab, Topiramate, Valproic Acid, Lithium Carbonate, Lithium Citrate, and Finasteride). Note that the following generic names include NDC codes with both oral and injection/intravenous pathways: warfarin, methotrexate, busulfan, and cyclophoshamide. The generic name Telavancin was queried, but no results were generated for this drug product. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in November 2011. This report includes information from 13 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to firstname.lastname@example.org.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.